Sanner set to debut expanded medical device, pharma packaging capabilities at Pharmapack 2027

Sanner executives will participate in two conference sessions on January 27.

FRANCE—Sanner will showcase its expanded pharmaceutical packaging and medical device services at Pharmapack Paris on January 27 to 28, 2027, as the company strengthens its capabilities in moisture management, sustainable design and global manufacturing.

At booth 4J59, the company will present solutions that address growing industry demands for product protection, environmental sustainability and supply chain resilience.

Expanded moisture management capabilities

Moisture control remains critical in pharmaceutical packaging, diagnostics and medical devices, where exposure to humidity can affect product stability, physical properties and shelf life.

To address these risks, Sanner has expanded its desiccant portfolio beyond conventional drop-in and integrated granular solutions to include hydrated, compressed and molded formats.

These options can be customized for different applications, from pharmaceutical primary packaging to drug delivery systems and diagnostic devices.

The company has also broadened its technical services to cover desiccant selection and sizing, humidity assessment, shelf-life simulation, component development, robustness testing and design for manufacturability.

“Our service commitment extends beyond desiccant products to tailored moisture management solutions for pharmaceutical, consumer health, and medical device applications,” said Jean-Edouard Rabier, CBDO at Sanner.

He noted that the company works with customers to develop moisture control solutions that meet product requirements while supporting scalable manufacturing.

Sustainability integrated into device development

Sanner is also expanding its sustainable packaging portfolio through mono-material designs that support recyclability, its BioBase® range of bio-based plastic solutions and its Tethered Cap concept, which keeps caps attached to tubes after opening.

Beyond packaging, the company is incorporating sustainability assessments into medical device development.

Its services include lifecycle assessments, device design optimization, supply chain and transport improvements, and end-of-life planning.

These approaches help manufacturers identify opportunities to reduce environmental impacts and measure improvements using lifecycle data.

Tom Oakley, VP Strategic Partnerships at Sanner, said manufacturers must consider sustainability early in the development process because medical devices can remain in production for many years.

He highlighted the need to balance environmental considerations with product performance and regulatory requirements.

Global manufacturing and supply chain resilience

Meanwhile, supply chain disruptions, material shortages, geopolitical uncertainty and changing demand continue to challenge healthcare manufacturers.

Sanner is addressing these pressures through manufacturing operations across Europe, the Americas and Asia, providing access to regional production capacity and closer proximity to customers.

According to CEO Stefan Verheyden, maintaining consistent quality across multiple manufacturing locations requires standardized processes, coordinated engineering expertise, transparent production planning and reliable supplier management.

These capabilities also allow the company to respond to regional market requirements while maintaining production consistency.

Sanner executives to participate in Pharmapack panels

In addition to exhibiting, Sanner executives will participate in two conference sessions on January 27.

Verheyden will chair a keynote panel titled “Formulation-Device Integration: Engineering for Commercial Reality” from 2:30 p.m. to 3:15 p.m.

Oakley will participate in “Age-Inclusive Device Design: Beyond Compliance to Usability” from 11:00 a.m. to 11:45 a.m.

Both discussions will take place at the Pharmapack Conference Theater.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on LinkedIn for updates.

Visited 14 times, 14 visit(s) today

Newer Post

Thumbnail for Sanner set to debut expanded medical device, pharma packaging capabilities at Pharmapack 2027

UN agencies warn prenatal exposure to endocrine-disrupting chemicals affects human development

Older Post

Thumbnail for Sanner set to debut expanded medical device, pharma packaging capabilities at Pharmapack 2027

PAHO urges Americas to intensify measles response as outbreaks threaten elimination

Be the first to leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *